AngioDynamics, Inc.
Device firm reports second quarter EPS up 50% to $0.09
Published in Lab Business Week, January 30th, 2005
Net sales for the second quarter of fiscal 2005 were $14.4 million, up 22%, compared with net sales of $11.9 million for the second quarter of fiscal year 2004. This increase was primarily due to strong growth from the company's newest products, along with continued market share gains across the entire product portfolio.
VenaCure, AngioDynamics' precision laser system for the treatment of severe varicose veins, continues to post robust sales growth. The company also had strong market penetration with its Morpheus CT PICC (peripherally inserted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-01-30)
More Articles from Lab Business Week
- Aeolus Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $2.06 per share - Affymetrix, Inc.
Genelabs gets $1.25M for amendment to DNA amplification technology license - Aradigm Corporation
Pharmaceutical firm announces $12.5M private placement financing - Arrowhead Research Corporation
Nanotech company named to Merrill Lynch index - Avanir Pharmaceuticals
Pharmaceutical firm reports loss of $0.09 per share - Avitar, Inc.
Diagnostics company reports loss of $0.12 per share - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
